Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Prostate Cancer

Free Subscription Articles published in Urology Retrieve available abstracts of 129 articles: HTML format

Single Articles

August 2022
1. HARRINGTON SA, Fialk G, Raman JD
   RE: "Transperineal Prostate Biopsy is Associated With Lower Tissue Core Pathogen Burden Relative to Transrectal Biopsy: Mechanistic Underpinnings for Lower Infection Risk in the Transperineal Approach".
   Urology. 2022;166:297-298.
   PubMed    
   
   
   July 2022
2. OKABE Y, Patel HD, Rac G, Gupta GN, et al
   Multifocality of Prostate Cancer and Candidacy for Focal Therapy Based on Magnetic Resonance Imaging.
   Urology. 2022 Jul 29. pii: S0090-4295(22)00631.
   PubMed     Abstract available
   
   
   
3. NASSIRI N, Richardson S, Kuppermann D, Brisbane WG, et al
   Partial gland ablation of prostate cancer: Effects of Repeat Treatment.
   Urology. 2022 Jul 27. pii: S0090-4295(22)00617.
   PubMed     Abstract available
   
   
   
4. CALLEJAS MF, Klein EA, Truong M, Thomas L, et al
   Detection of clinically significant index prostate cancer using micro-ultrasound: correlation with radical prostatectomy.
   Urology. 2022 Jul 14. pii: S0090-4295(22)00592.
   PubMed     Abstract available
   
   
   
5. DE BARROS HA, Remmers S, Luiting HB, van Leenders GJLH, et al
   Predictive value of Cribriform and Intraductal Carcinoma for the Nomogram-Based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.
   Urology. 2022 Jul 5. pii: S0090-4295(22)00537.
   PubMed     Abstract available
   
   
   
6. WERNEBURG GT, Adler A, Zhang A, Mukherjee SD, et al
   Transperineal Prostate Biopsy is Associated With Lower Tissue Core Pathogen Burden Relative to Transrectal Biopsy: Mechanistic Underpinnings for Lower Infection Risk in the Transperineal Approach.
   Urology. 2022;165:1-8.
   PubMed     Abstract available
   
   
   
7. HARRISON R, Stifelman M, Billah M, Zaifman J, et al
   Propensity-Score Matched Analysis Between Extraperitoneal Single Port and Intraperitoneal Multiport Radical Prostatectomy: A Single-Institutional Experience.
   Urology. 2022;165:198-205.
   PubMed     Abstract available
   
   
   
8. LANE GI, Qi J, Dupati A, Ferrante S, et al
   Assessing the Impact of Decision Aid Use on Post Prostatectomy Patient Reported Outcomes.
   Urology. 2022;165:187-192.
   PubMed     Abstract available
   
   
   
9. SLOPNICK EA, Bagby C, Mahran A, Nagel C, et al
   Skene's Gland Malignancy: A Case Report and Systematic Review.
   Urology. 2022;165:36-43.
   PubMed     Abstract available
   
   
   June 2022
10. DELANEY RK, Sisco-Taylor BL, Wang X, Scherr K, et al
    Two Specialists, Two Recommendations: Discordance between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations.
    Urology. 2022 Jun 26. pii: S0090-4295(22)00512.
    PubMed     Abstract available
    
    
    
11. BENIDIR T, Hofmann M, Lone Z, Nguyen JK, et al
    Elevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature.
    Urology. 2022 Jun 6. pii: S0090-4295(22)00449.
    PubMed     Abstract available
    
    
    
12. JEONG SH, Werneburg GT, Abouassaly R, Wood H, et al
    Acquired and Congenital Spinal Cord Injury is Associated With Lower Likelihood of Prostate Specific Antigen Screening.
    Urology. 2022;164:178-183.
    PubMed     Abstract available
    
    
    
13. CHIU PKF, Ahmed HU, Rastinehad AR
    TRUS Biopsy vs Transperineal Biopsy for Suspicion of Prostate Cancer.
    Urology. 2022;164:18-20.
    PubMed    
    
    
    
14. TOSOIAN JJ, Singhal U, Davenport MS, Wei JT, et al
    Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.
    Urology. 2022;164:184-190.
    PubMed     Abstract available
    
    
    April 2022
15. GOLDENTHAL SB, Reimers MA, Singhal U, Farha M, et al
    Prostate Cancer with Peritoneal Carcinomatosis: A robotic-assisted radical prostatectomy-based Case Series.
    Urology. 2022 Apr 23. pii: S0090-4295(22)00296.
    PubMed     Abstract available
    
    
    March 2022
16. PINO MD, Abern MR, Moreira DM
    Prostate Cancer Disparities in Hispanics using the National Cancer Database.
    Urology. 2022 Mar 26. pii: S0090-4295(22)00256.
    PubMed     Abstract available
    
    
    
17. LOWENTRITT B, Brown G, Pilon D, Ellis L, et al
    Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer.
    Urology. 2022 Mar 19. pii: S0090-4295(22)00245.
    PubMed     Abstract available
    
    
    
18. NASRI J, Barthe F, Parekh S, Ratnani P, et al
    Nomogram predicting adverse pathology outcome on radical prostatectomy in low-risk prostate cancer men.
    Urology. 2022 Mar 6. pii: S0090-4295(22)00173.
    PubMed     Abstract available
    
    
    
19. KUPERUS JM, Tobert CM, Semerjian AM, Qi J, et al
    Pelvic Lymph Node Dissection at Radical Prostatectomy for Intermediate Risk Prostate Cancer: Assessing Utility and Nodal Metastases Within a Statewide Quality Improvement Consortium.
    Urology. 2022 Mar 6. pii: S0090-4295(22)00166.
    PubMed     Abstract available
    
    
    
20. BEARRICK EN, Findlay BL, Maciejko LA, Hebert KJ, et al
    Robotic Urethral Reconstruction Outcomes in Men With Posterior Urethral Stenosis.
    Urology. 2022;161:118-124.
    PubMed     Abstract available
    
    
    February 2022
21. MASON MM, Nackeeran S, Lokeshwar SD, Blachman-Braun R, et al
    PSA Testing in Men Receiving Testosterone Therapy with History of Prostate Cancer: A Matched Analysis of a Large Multi-Institutional Research Network.
    Urology. 2022 Feb 25. pii: S0090-4295(22)00161.
    PubMed     Abstract available
    
    
    
22. LIM M, Qureshi MM, Boyd G, Hirsch AE, et al
    Effect of Radiation Treatment at a High-Volume Center on Outcomes in Intermediate-Risk Prostate Cancer: An Analysis of the National Cancer Database.
    Urology. 2022 Feb 16. pii: S0090-4295(22)00144.
    PubMed     Abstract available
    
    
    
23. HACKER EC, Maganty A, Pere MM, Rusilko PJ, et al
    Outcomes of Vesicourethral Anastomotic Stenosis and Bladder Neck Contracture with Direct Visual Internal Urethrotomy with Mitomycin-C After Prostate Cancer Treatment.
    Urology. 2022 Feb 12. pii: S0090-4295(22)00110.
    PubMed     Abstract available
    
    
    
24. LAVI A, Yudkevich B, Pechansky S, Tzemach S, et al
    Author Reply.
    Urology. 2022;160:159.
    PubMed    
    
    
    January 2022
25. VERSALLE D, Qi J, Noyes S, Moriarity A, et al
    Practice-level variation in the decision to biopsy PI-RADS 3 lesions in favorable-risk prostate cancer patients.
    Urology. 2022 Jan 23. pii: S0090-4295(22)00070.
    PubMed     Abstract available
    
    
    
26. KOTAMARTI S, George A, Zhu A, Polascik TJ, et al
    Transrectal Ultrasound-Guided Biopsy Should Continue to Be a Standard of Care for The Detection of Prostate Cancer.
    Urology. 2022 Jan 14. pii: S0090-4295(22)00018.
    PubMed     Abstract available
    
    
    
27. ROEBUCK E, Sha W, Lu C, Miller C, et al
    Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate Cancer.
    Urology. 2022 Jan 4. pii: S0090-4295(21)01201.
    PubMed     Abstract available
    
    
    
28. REDMOND EJ, Doiron RC, Rourke KF
    Development of New Comorbidities in Patients Awaiting Urinary Incontinence Surgery Following Radical Prostatectomy.
    Urology. 2022;159:235-240.
    PubMed     Abstract available
    
    
    December 2021
29. NAKAI Y, Tanaka N, Asakawa I, Miyake M, et al
    Mirabegron reduces urinary frequency and improves overactive bladder symptoms at 3 months after (125)I-brachytherapy for prostate cancer: An open-labeled, randomized, non-placebo-controlled study.
    Urology. 2021 Dec 29. pii: S0090-4295(21)01183.
    PubMed     Abstract available
    
    
    
30. WITTMANN D, Varlamos C, Rodriguez-Galano N, Day L, et al
    Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction with a Survivorship Program Embedded in Urologic-oncologic Care.
    Urology. 2021 Dec 8. pii: S0090-4295(21)01153.
    PubMed     Abstract available
    
    
    
31. SABA P, Melnyk R, Holler T, Oppenheimer D, et al
    Comparison of Multi-Parametric MRI of the Prostate to 3D Prostate Computer Aided Designs and 3D-Printed Prostate Models for Pre-Operative Planning of Radical Prostatectomies: A Pilot Study.
    Urology. 2021;158:150-155.
    PubMed     Abstract available
    
    
    November 2021
32. LAVI A, Yudkevich B, Pechansky S, Tzemach S, et al
    Implications of a Novel Biopsy Downloading System on Prostate Cancer Detection Rate, Surveillance and Focal Therapy - A Prospective Study.
    Urology. 2021 Nov 12. pii: S0090-4295(21)01039.
    PubMed     Abstract available
    
    
    
33. VERTOSICK EA, Zappala S, Punnen S, Hugosson J, et al
    Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume.
    Urology. 2021;157:102-106.
    PubMed     Abstract available
    
    
    
34. LORENZ U, Samaseika Y, Balsmeyer U, Neumann N, et al
    Multicystic Prostate Tumor.
    Urology. 2021;157:41.
    PubMed    
    
    
    October 2021
35. SEIDEN B, Weng S, Sun N, Gordon D, et al
    NCCN Risk Reclassification in Black men with low and intermediate risk Prostate Cancer after genomic testing.
    Urology. 2021 Oct 21. pii: S0090-4295(21)00979.
    PubMed     Abstract available
    
    
    
36. SPITZNAGEL T, Hardenberg JV, Schmid FA, Rupp NJ, et al
    Salvage Robotic-assisted Laparoscopic Radical Prostatectomy Following Focal High-Intensity Focused Ultrasound for ISUP 2/3 Cancer.
    Urology. 2021;156:147-153.
    PubMed     Abstract available
    
    
    September 2021
37. ESDAILLE AR, Ibilibor C, Ii AH, Palmer NR, et al
    Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer.
    Urology. 2021 Sep 25. pii: S0090-4295(21)00893.
    PubMed     Abstract available
    
    
    
38. BERTOLO R, Garisto J, Bove P, Mottrie A, et al
    Perioperative Outcomes Between Single-Port and "Multi-Port" Robotic Assisted Radical Prostatectomy: Where do we stand?
    Urology. 2021;155:138-143.
    PubMed     Abstract available
    
    
    
39. DE LA CALLE CM, Shee K, Chu CE, Cowan JE, et al
    Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance.
    Urology. 2021;155:91-95.
    PubMed     Abstract available
    
    
    
40. PRESS BH, Khajir G, Ghabili K, Leung C, et al
    Utility of PSA Density in Predicting Upgraded Gleason Score in Men on Active Surveillance With Negative MRI.
    Urology. 2021;155:96-100.
    PubMed     Abstract available
    
    
    
41. SAYYID RK, Klotz L, Benton JZ, Lodh A, et al
    Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance Patients.
    Urology. 2021;155:117-123.
    PubMed     Abstract available
    
    
    
42. CHECCUCCI E, Piramide F, Amparore D, De Cillis S, et al
    Beyond the Learning Curve of Prostate MRI/TRUS Target Fusion Biopsy after More than 1000 Procedures.
    Urology. 2021;155:39-45.
    PubMed     Abstract available
    
    
    
43. CRICCO-LIZZA E, Wilcox Vanden Berg RN, Laviana A, Pantuck M, et al
    Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation.
    Urology. 2021;155:33-38.
    PubMed     Abstract available
    
    
    
44. LEE AY, Chen K, Law YM, Ho HS, et al
    Robot-assisted Magnetic Resonance Imaging-ultrasound Fusion Transperineal Targeted Biopsy.
    Urology. 2021;155:46.
    PubMed     Abstract available
    
    
    
45. WEI G, Papa N, Kelly B, Bolton D, et al
    Trends in the Uptake of Diagnostic Multi-Parametric MRI of the Prostate With Federal Funding: Australia Population Data.
    Urology. 2021;155:9-11.
    PubMed    
    
    
    
46. BRIGGS LG, Kim M, Gusev A, Rumpf F, et al
    Evaluation of In-Office MRI/US Fusion Transperineal Prostate Biopsy via Free-hand Device during Routine Clinical Practice.
    Urology. 2021;155:26-32.
    PubMed     Abstract available
    
    
    
47. LEVY A, Fleishman A, Jackson M, Waisman A, et al
    Using Preoperative Pelvic Floor Assessment to Predict Early Return of Continence after Robotic Radical Prostatectomy.
    Urology. 2021;155:160-164.
    PubMed     Abstract available
    
    
    
48. ALTOK M, Chapin BF, Matin SF, Achim MF, et al
    Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase.
    Urology. 2021;155:144-151.
    PubMed     Abstract available
    
    
    
49. MEHTA A, Kim WC, Aswad KG, Brunckhorst O, et al
    Erectile Function Post Prostate Biopsy: A Systematic Review and Meta-analysis.
    Urology. 2021;155:1-8.
    PubMed     Abstract available
    
    
    August 2021
50. BREE KK, Hensley PJ, Pettaway CA
    Germline Mutations in African American Men with Prostate Cancer: Incidence, Implications and Diagnostic Disparities.
    Urology. 2021 Aug 25. pii: S0090-4295(21)00796.
    PubMed     Abstract available
    
    
    
51. POSIELSKI N, Frankel J, Kuo HC, Ho O, et al
    IMPACT OF AGE AND RACE ON HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER.
    Urology. 2021 Aug 21. pii: S0090-4295(21)00783.
    PubMed     Abstract available
    
    
    
52. VINCE RA JR, Jamieson S, Mahal B, Iii WU, et al
    Examining the Racial Disparities in Prostate Cancer.
    Urology. 2021 Aug 18. pii: S0090-4295(21)00772.
    PubMed     Abstract available
    
    
    
53. BERG RNWV, Basourakos SP, Shoag J, Scherr D, et al
    Prostate Cancer Screening for Gay Men in the United States.
    Urology. 2021 Aug 8. pii: S0090-4295(21)00734.
    PubMed     Abstract available
    
    
    
54. JAMIESON SC, Mallory CW, Jivanji DR, Perez A, et al
    THE ROLE OF HEALTH LITERACY IN PROSTATE CANCER SCREENING.
    Urology. 2021 Aug 7. pii: S0090-4295(21)00735.
    PubMed     Abstract available
    
    
    
55. LEWICKI P, Arenas-Gallo C, Basourakos SP, Awamlh BAHA, et al
    Re: Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, et al. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. Urology 2021 Jun 26;S0090-4295(21)00539-2.
    Urology. 2021 Aug 3. pii: S0090-4295(21)00722.
    PubMed    
    
    
    
56. BORGES DA PONTE C, Leitao TP, Miranda M, Polido J, et al
    Prostate Ewing Sarcoma/PNET: A case of long survival in a highly aggressive malignancy.
    Urology. 2021;154:e11-e12.
    PubMed     Abstract available
    
    
    July 2021
57. DEROUEN MC, Yang J, Jain J, Weden MM, et al
    Disparities in prostate cancer survival according to neighborhood archetypes, a population-based study.
    Urology. 2021 Jul 22. pii: S0090-4295(21)00674.
    PubMed     Abstract available
    
    
    
58. PATEL HD, Doshi CP, Koehne EL, Hart S, et al
    African American Men have Increased Risk of Prostate Cancer Detection despite Similar Rates of Anterior Prostatic Lesions and PI-RADS Grade on Multiparametric Magnetic Resonance Imaging.
    Urology. 2021 Jul 21. pii: S0090-4295(21)00678.
    PubMed     Abstract available
    
    
    
59. SESSINE MS, Das S, Park B, Salami SS, et al
    Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
    Urology. 2021 Jul 16. pii: S0090-4295(21)00647.
    PubMed     Abstract available
    
    
    
60. GAYLIS F, Nasseri R, Salmasi A, Anderson C, et al
    Implementing Continuous Quality Improvement in an Integrated Community Urology Practice: Lessons Learned.
    Urology. 2021;153:139-146.
    PubMed     Abstract available
    
    
    
61. WARNER JN, Gallegos MA
    Letter to the Editor RE: Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021;153:359-360.
    PubMed    
    
    
    
62. SHAH N, Ioffe V
    Re: Letter to the Editor: Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis. Deepansh Dalela et al. (Urology 2021;148:1-3).
    Urology. 2021;153:360-361.
    PubMed    
    
    
    June 2021
63. PIERRE-VICTOR D, Parnes HL, Andriole GL, Pinsky PF, et al
    Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening.
    Urology. 2021 Jun 26. pii: S0090-4295(21)00539.
    PubMed     Abstract available
    
    
    
64. CHANDRASEKAR T, Bowler N, Schneider A, Goldberg H, et al
    Outcomes of Active Surveillance for Men with Intermediate Risk Prostate Cancer, A Population-Based Analysis.
    Urology. 2021 Jun 26. pii: S0090-4295(21)00560.
    PubMed     Abstract available
    
    
    
65. KAWA SM, Stroomberg HV, Larsen SB, Helgstrand JT, et al
    Detection of clinically significant prostate cancer by systematic TRUS-biopsies in a population-based setting over a 20 year period.
    Urology. 2021 Jun 22. pii: S0090-4295(21)00538.
    PubMed     Abstract available
    
    
    
66. CAMPBELL RA, Li J, Malone L, Levy DA, et al
    Correlative Analysis of Vitamin D and Omega-3 Fatty Acid Intake in Men on Active Surveillance for Prostate Cancer.
    Urology. 2021 Jun 15. pii: S0090-4295(21)00525.
    PubMed     Abstract available
    
    
    
67. SOERENSEN SJC, Thomas IC, Schmidt B, Daskivich T, et al
    Reply to the Editorial Comment on: Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021.
    Urology. 2021 Jun 14. pii: S0090-4295(21)00488.
    PubMed     Abstract available
    
    
    
68. CHAO B, Lepor H
    5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer.
    Urology. 2021 Jun 3. pii: S0090-4295(21)00460.
    PubMed     Abstract available
    
    
    May 2021
69. HESTERBERG AB, Gordetsky JB, Hurley PJ
    Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.
    Urology. 2021 May 28. pii: S0090-4295(21)00442.
    PubMed     Abstract available
    
    
    
70. KING MC, Sardi A, Velez-Mejia C, Sittig M, et al
    Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate Cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Urology. 2021 May 25. pii: S0090-4295(21)00435.
    PubMed     Abstract available
    
    
    
71. ARMSTRONG N, Bahl A, Pinkawa M, Ryder S, et al
    SpaceOAR Hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review.
    Urology. 2021 May 22. pii: S0090-4295(21)00421.
    PubMed     Abstract available
    
    
    
72. SCHUBBE ME, Gellhaus PT, Tobert CM, Mott SL, et al
    Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life.
    Urology. 2021 May 7. pii: S0090-4295(21)00368.
    PubMed     Abstract available
    
    
    
73. KF R
    Re: Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021 May 1. pii: S0090-4295(21)00355.
    PubMed    
    
    
    April 2021
74. PAUDEL R, Ferrante S, Qi J, Dunn RL, et al
    Patient preferences and treatment decisions for prostate cancer: Results from a statewide urological quality improvement collaborative.
    Urology. 2021 Apr 29. pii: S0090-4295(21)00350.
    PubMed     Abstract available
    
    
    
75. NORRIS JM, Ball R, Freeman A, Ghei M, et al
    Patient Perspectives and Understanding of MRI-Directed Prostate Cancer Diagnosis.
    Urology. 2021 Apr 3. pii: S0090-4295(21)00301.
    PubMed    
    
    
    March 2021
76. MADI R, Sayyid RK, Hiffa A, Thomas E, et al
    Early Experience with Salvage Retzius-sparing Robotic-assisted Radical Prostatectomy: Oncologic and Functional Outcomes.
    Urology. 2021;149:117-121.
    PubMed     Abstract available
    
    
    
77. LINDSAY J, Uribe S, Moschonas D, Pavlakis P, et al
    Patient Satisfaction and Regret After Robot-assisted Radical Prostatectomy: A Decision Regret Analysis.
    Urology. 2021;149:122-128.
    PubMed     Abstract available
    
    
    
78. NAITO H, Kato T, Ishikawa R, Tanaka K, et al
    The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 2.
    Urology. 2021;149:174-180.
    PubMed     Abstract available
    
    
    
79. WONG D, Rincon J, Henning G, Smith Z, et al
    Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates.
    Urology. 2021;149:129-132.
    PubMed     Abstract available
    
    
    
80. GUERRIOS-RIVERA L, Howard LE, Klaassen Z, Terris MK, et al
    Do Hispanic Men Have Worse Outcomes After Radical Prostatectomy? Results From SEARCH.
    Urology. 2021;149:181-186.
    PubMed     Abstract available
    
    
    February 2021
81. SAPIENZA LG, Ning MS, Carvalho EF, Spratt D, et al
    Efficacy and Incontinence Rates After Urethroplasty for Radiation-Induced Urethral Stenosis: A Systematic Review and Meta-Analysis.
    Urology. 2021 Feb 22. pii: S0090-4295(21)00190.
    PubMed     Abstract available
    
    
    
82. MARCHETTI KA, Oerline M, Hollenbeck BK, Kaufman SR, et al
    Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees.
    Urology. 2021 Feb 18. pii: S0090-4295(21)00182.
    PubMed     Abstract available
    
    
    
83. WOON DTS, Finelli A, Cheung DC, Martin LJ, et al
    A population-based study comparing outcomes for patients with metastatic castrate resistant prostate cancer treated by urologists or medical oncologists with first line abiraterone acetate or enzalutamide.
    Urology. 2021 Feb 13. pii: S0090-4295(21)00172.
    PubMed     Abstract available
    
    
    
84. POSIELSKI NM, Richards KA, Liou JI, Borza T, et al
    Beta-Adrenergic Antagonists and Cancer Specific Survival in Patients with Advanced Prostate Cancer: A Veterans Administration Cohort Study.
    Urology. 2021 Feb 12. pii: S0090-4295(21)00173.
    PubMed     Abstract available
    
    
    
85. HEMAL S, DeWitt-Foy M, Klein EA
    Management of a Prostate Cancer Patient with inherited germline BRCA1 and BRCA2 mutations, a Case Report.
    Urology. 2021 Feb 5. pii: S0090-4295(21)00120.
    PubMed     Abstract available
    
    
    
86. VOELZKE BB, Leddy LS, Myers JB, Breyer BN, et al
    Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021 Feb 5. pii: S0090-4295(21)00121.
    PubMed     Abstract available
    
    
    
87. JIBARA G, Sjoberg DD, Stearns GL, Stabholz Y, et al
    Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance.
    Urology. 2021 Feb 1. pii: S0090-4295(21)00112.
    PubMed     Abstract available
    
    
    
88. DALELA D, Sood A, Keeley J, Rogers C, et al
    Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis.
    Urology. 2021;148:1-3.
    PubMed    
    
    
    
89. KUBOTA M, Matsuoka T, Yamasaki T, Kokubun H, et al
    Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy.
    Urology. 2021;148:151-158.
    PubMed     Abstract available
    
    
    
90. ETAFY MH, Katz JE, Gonzalgo MR, Garcia Lopez EA, et al
    Holmium Laser Enucleation of Prostate Within 6 Weeks of Transrectal Ultrasound Guided Prostate Biopsy is Safe and Effective.
    Urology. 2021;148:88-92.
    PubMed     Abstract available
    
    
    January 2021
91. MICHAEL J, Khandani AH, Basak R, Tan HJ, et al
    Patterns of recurrence, detection rates, and impact of 18-F Fluciclovine PET/CT on the management of men with recurrent prostate cancer.
    Urology. 2021 Jan 29. pii: S0090-4295(21)00110.
    PubMed     Abstract available
    
    
    
92. HUYNH LM, Keit E, Huang E, Et Al, et al
    Protective Effects of Metformin against Biochemical Failure Following Radical Prostatectomy or Radiation Therapy in Localized Prostate Cancer.
    Urology. 2021 Jan 27. pii: S0090-4295(21)00092.
    PubMed     Abstract available
    
    
    
93. XU J, Bock C, Janisse J, Schwartz KL, et al
    Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients.
    Urology. 2021 Jan 19. pii: S0090-4295(21)00064.
    PubMed     Abstract available
    
    
    
94. HUANG MM, Patel HD, Wainger JJ, Su ZT, et al
    Comparison of Perioperative and Pathologic Outcomes Between Single-port and Standard Robot-assisted Radical Prostatectomy: An Analysis of a High-volume Center and the Pooled World Experience.
    Urology. 2021;147:223-229.
    PubMed     Abstract available
    
    
    December 2020
95. HOFMANN MR, Hussain M, Dehm SM, Beltran H, et al
    Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary.
    Urology. 2020 Dec 26. pii: S0090-4295(20)31519.
    PubMed     Abstract available
    
    
    
96. HANDLEY NR, Feng FY, Guise TA, D'Andrea D, et al
    Preserving Well-being in Patients With Advanced and Late Prostate Cancer.
    Urology. 2020 Dec 26. pii: S0090-4295(20)31513.
    PubMed     Abstract available
    
    
    
97. MCMAHON S, Basak R, Zhou X, Smith AB, et al
    Patient-Reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment.
    Urology. 2020 Dec 19. pii: S0090-4295(20)31498.
    PubMed     Abstract available
    
    
    
98. ALANEE S, Peabody J, Menon M
    Prostate Cancer Undetected by mpMRI: Tumour Conspicuity is Reliant Upon Optimal Scan Timing and Quality.
    Urology. 2020 Dec 3. pii: S0090-4295(20)31428.
    PubMed    
    
    
    
99. NORRIS JM, Allen C, Ball R, Freeman A, et al
    Prostate Cancer Undetected by mpMRI: Tumour Conspicuity is Reliant Upon Optimal Scan Timing and Quality.
    Urology. 2020 Dec 2. pii: S0090-4295(20)31427.
    PubMed    
    
    
    November 2020
100. SCHMANKE K, Okut H, Ablah E
     Trends for Stage and Grade Group of Prostate Cancer in the US (2010-2016).
     Urology. 2020 Nov 20. pii: S0090-4295(20)31399.
     PubMed     Abstract available
     
     
     
101. BHATTU AS, Zappala SM, Parekh DJ, Punnen S, et al
     A 4Kscore cut-off of 7.5% for prostate biopsy decisions provides high sensitivity and negative predictive value for significant prostate cancer.
     Urology. 2020 Nov 17. pii: S0090-4295(20)31371.
     PubMed     Abstract available
     
     
     
102. GREENBERG JW, Leinwand G, Feibus AH, Haney NM, et al
     Prospective Observational Study of a Racially Diverse Group of Men on Active Surveillance for Prostate Cancer.
     Urology. 2020 Nov 6. pii: S0090-4295(20)31346.
     PubMed     Abstract available
     
     
     October 2020
103. SOETERIK TFW, van Melick HHE, Dijksman LM, Biesma DH, et al
     Multi-parametric magnetic resonance imaging should be preferred over digital rectal examination for prostate cancer local staging and disease risk classification.
     Urology. 2020 Oct 28. pii: S0090-4295(20)31296.
     PubMed     Abstract available
     
     
     
104. DE ALMEIDA RVS, Silvino JRC, Kalil JR, Junior VLDS, et al
     Early Effects of High-Intensity Focused Ultrasound (HIFU) Treatment for Prostate Cancer on Fecal Continence and Anorectal Physiology.
     Urology. 2020 Oct 17. pii: S0090-4295(20)31265.
     PubMed     Abstract available
     
     
     September 2020
105. WINOKER JS, Wajswol E, Falagario U, Maritini A, et al
     Transperineal versus transrectal targeted biopsy with use of electromagnetically-tracked MR/US fusion guidance platform for the detection of clinically significant prostate cancer.
     Urology. 2020 Sep 18. pii: S0090-4295(20)31137.
     PubMed     Abstract available
     
     
     
106. GINSBURG KB, Jacobs JC, Qi J, Kaye DR, et al
     Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance.
     Urology. 2020 Sep 15. pii: S0090-4295(20)31125.
     PubMed     Abstract available
     
     
     
107. ALANEE S, Deebajah M, Taneja K, Cole D, et al
     Post prostatectomy Pathologic Findings of Patients with Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging.
     Urology. 2020 Sep 15. pii: S0090-4295(20)31127.
     PubMed     Abstract available
     
     
     
108. SHIRK JD
     RE: 3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review.
     Urology. 2020 Sep 9. pii: S0090-4295(20)31012.
     PubMed    
     
     
     August 2020
109. KARSIYAKALI N, Ozgen MB, Ozveren B, Akbal C, et al
     Sub-optimal Prediction of Clinically Significant Prostate Cancer in Radical Prostatectomy Specimens by mpMRI-Targeted Biopsy.
     Urology. 2020 Aug 29. pii: S0090-4295(20)31028.
     PubMed     Abstract available
     
     
     
110. THOMAS L, Sharifi N
     Germline HSD3B1 Genetics and Prostate Cancer Outcomes.
     Urology. 2020 Aug 28. pii: S0090-4295(20)31025.
     PubMed     Abstract available
     
     
     
111. WAKE N, Bjurlin MA
     Author Reply: 3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review.
     Urology. 2020 Aug 28. pii: S0090-4295(20)31010.
     PubMed    
     
     
     
112. LAMBA N, Butler S, Mahal BA, Trinh QD, et al
     Three-tiered sub-classification system of high-risk prostate cancer in men managed with radical prostatectomy: Implications for treatment decision-making.
     Urology. 2020 Aug 4. pii: S0090-4295(20)30949.
     PubMed     Abstract available
     
     
     
113. KAHOKEHR AA, Boysen WR, Schild MH, Nose BD, et al
     Urinary pubic symphysis fistula leads to histopathologic osteomyelitis in prostate cancer survivors.
     Urology. 2020 Aug 4. pii: S0090-4295(20)30947.
     PubMed     Abstract available
     
     
     July 2020
114. WU Y, Wang Y, Gu Y, Xia J, et al
     Prostate Cancer Risk and Prognostic Influence Among Users of 5-Alpha-Reductase Inhibitors and Alpha-Blockers: A Systematic Review and Meta-Analysis.
     Urology. 2020 Jul 31. pii: S0090-4295(20)30932.
     PubMed     Abstract available
     
     
     
115. CIPRUT SE, Kelly MD, Walter D, Hoffman R, et al
     A Clinical Reminder Order Check (CROC) Intervention to Improve Guideline-Concordant Imaging Practices for men with Prostate Cancer: A Pilot Study.
     Urology. 2020 Jul 25. pii: S0090-4295(20)30888.
     PubMed     Abstract available
     
     
     
116. BARQAWI A, Pessoa RR, Al-Musawi M, MacDermott T, et al
     THE IMPACT OF PERFORMING A 3D MAPPING BIOPSY PRIOR TO PRIMARY CRYOTHERAPY FOR THE TREATMENT OF PROSTATE CANCER.
     Urology. 2020 Jul 22. pii: S0090-4295(20)30867.
     PubMed     Abstract available
     
     
     
117. MATSUGASUMI T, Shiraishi T, Fujihara A, Ohashi M, et al
     Targeted focal cryoablation for prostate cancer with real-time Transrectal Ultrasound guided free-hands technique: A step-by-step technique.
     Urology. 2020 Jul 16. pii: S0090-4295(20)30847.
     PubMed     Abstract available
     
     
     
118. O'CONNOR LP, Wang AZ, Yerram NK, Lebastchi AH, et al
     Combined MRI-targeted plus systematic confirmatory biopsy improves risk stratification for patients enrolling on active surveillance for prostate cancer.
     Urology. 2020 Jul 14. pii: S0090-4295(20)30828.
     PubMed     Abstract available
     
     
     
119. YAN H, Dittmar F, Schagdarsurengin U, Wagenlehner F, et al
     The clinical application and potential roles of circulating tumor cells in bladder cancer and prostate cancer.
     Urology. 2020 Jul 4. pii: S0090-4295(20)30799.
     PubMed     Abstract available
     
     
     June 2020
120. WAKE N, Nussbaum JE, Elias MI, Nikas CV, et al
     3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review.
     Urology. 2020 Jun 11. pii: S0090-4295(20)30663.
     PubMed     Abstract available
     
     
     
121. CULLEN J, Kuo HC, Shan J, Lu R, et al
     The 17-Gene Genomic Prostate Score Test as a Predictor of Outcomes in Men with Unfavorable Intermediate Risk Prostate Cancer.
     Urology. 2020 Jun 7. pii: S0090-4295(20)30623.
     PubMed     Abstract available
     
     
     
122. KAUFMAN ME, Miller DT, Ullah A, White J, et al
     Skene's Gland Adenocarcinoma: Borrowing from Prostate Cancer Experience for the Evaluation and Management of a Rare Malignancy.
     Urology. 2020 Jun 3. pii: S0090-4295(20)30632.
     PubMed     Abstract available
     
     
     May 2020
123. IINUMA K, Nakano M, Kato T, Kato D, et al
     Assessment of long-term changes in lower urinary tract symptoms in patients with prostate cancer who underwent low-dose-rate prostate brachytherapy.
     Urology. 2020 May 13. pii: S0090-4295(20)30540.
     PubMed     Abstract available
     
     
     
124. NOSE BD, Boysen WR, Kahokehr AA, Inouye BM, et al
     Extirpative cultures reveal infectious pubic bone osteomyelitis in prostate cancer survivors with urinary-pubic symphysis fistulae (UPF).
     Urology. 2020 May 7. pii: S0090-4295(20)30520.
     PubMed     Abstract available
     
     
     April 2020
125. FROEHNER M, Koch R, Hubler M, Lindner M, et al
     Quantifying the relationship between increasing life expectancy and non-prostate cancer mortality after radical prostatectomy.
     Urology. 2020 Apr 22. pii: S0090-4295(20)30435.
     PubMed     Abstract available
     
     
     
126. PARTIN AW
     Commentary RE: Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium & Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Glea
     Urology. 2020 Apr 17. pii: S0090-4295(20)30422.
     PubMed    
     
     
     
127. BARRY M, Fowler J
     Commentary RE: Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey.
     Urology. 2020 Apr 16. pii: S0090-4295(20)30401.
     PubMed    
     
     
     
128. WYSOCK JS, Becher E, Persily J, Loeb S, et al
     Concordance and Performance of 4Kscore(R) and SelectMDx(R) for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer.
     Urology. 2020 Apr 12. pii: S0090-4295(20)30339.
     PubMed     Abstract available
     
     
     January 2020
129. PATEL MS, Halpern JA, Desai AS, Keeter MK, et al
     Success of Prostate and Testicular Cancer Awareness Campaigns Compared to Breast Cancer Awareness Month According to Internet Search Volumes: A Google Trends Analysis.
     Urology. 2020 Jan 27. pii: S0090-4295(20)30081.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: